# Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers

> **NCT00416845** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 39 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** FTY720

## Key facts

- **NCT ID:** NCT00416845
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-03
- **Final completion:** —
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2010-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00416845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00416845, "Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00416845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*